Skip to content

Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery

Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery,A Randomized Controlled Double-Blinded Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02644980
Enrollment
110
Registered
2016-01-01
Start date
2015-12-31
Completion date
2016-08-31
Last updated
2016-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium, Hemodynamic Instability

Keywords

Target Controlled Infusion

Brief summary

For patients requiring the heart valve replacement surgery, heart function is injured in different degree.Thus, minimizing the impact of the anesthesia drug on the cardiovascular system has important clinical meanings. Etomidate has slight effect on the cardiovascular system, often used in the induction of anesthesia, however target controlled infusion etomidate in maintenance of anesthesia is less used. So, the trial is designed to observe the application value of TCI etomidate in thoracoscopic mitral valve replacement surgery.

Interventions

DRUGPropofol

The initiate drug concentration of propofol is set to 1.0 μg/ml, increasing 0.3 μg/ml every minutes until the BIS(Bispectral index ) reaches 40\ 60.

DRUGEtomidate

The initiate drug concentration of etomidate is set to 0.2 μg/ml, increasing 0.1 μg/ml every minutes until the BIS(Bispectral index ) reaches 40\ 60.

BIS monitored from beginning of anesthesia induction to the end of the surgery.

DRUGInduction of anesthesia

Midazolam 0.03 mg/kg injection vein,Sufentanyl 0.5\ 1 μg/kg, target controlled infusion of etomidate or propofol,after the consciousness of patients is lost, rocuronium 0.6mg/kg is given.

After the intubation, target controlled infusion(TCI) of etomidate or propofol is maintained,rocuronium 0.15mg/kg and sufentanil is given when needed. When the operation is over, the TCI is stopped.

OTHERTracheal Intubation

After the induction of anesthesia, Tracheal intubation is performed.

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18\ 75 years old 2. Selective cardiopulmonary bypass thoracoscopic mitral vales replacement surgery 3. Received heart surgery for the first time 4. New York Heart Association(NYHA) II\ III 5. Written informed consent -

Exclusion criteria

1. Emergency surgery 2. Anticipated survival time \<1 yrs 3. Serious heart, brain, liver,kidney,lung,endocrine diseases or serious infection 4. Prolonged use of hormone or history of adrenal suppression disease 5. Severe mediastinal fiber thickening or fibrous adhesions 6. Allergy to experimental drug or other contraindications 7. Occurred or expected occurring of difficulty airway 8. Sure or suspected narcotic analgesics abuse 9. History of neuro-muscular disease 10. Mental instability or metal disease 11. Pregnancy or brest-feeding 12. Participated other clinical trial past 30 days 13. Malignant hyperthermia

Design outcomes

Primary

MeasureTime frameDescription
Blood pressurefrom the beginning of induction to the surgery over, up to 6 hrs.blood pressure(systolic blood pressure and diastolic blood pressure) is monitored and recorded at 9 time points, including 10 minutes before induction,the right moment after induction of anesthesia and tracheal intubation,the beginning of surgery and the cardiopulmonary bypass(CPB),the time the ascending aorta is blocked and unstuck,the time the CPB and the surgery is over.

Secondary

MeasureTime frameDescription
Life qualityat the time of one month right after the surgeryusing the Activities of Daily Living (ADL) to assess the life quality one month after the surgery.
Time of recovery from anesthesiafrom the time TCI is stopped to the time patients' eyes open after the surgery, up to 30 minutes.
Bispectral index (BIS) valuefrom the beginning of induction to the surgery over, up to 6 hrs.BIS is monitored and recorded at 9 time points, including 10 minutes before induction,the right moment after induction of anesthesia and tracheal intubation,the beginning of surgery and the cardiopulmonary bypass(CPB),the time the ascending aorta is blocked and unstuck,the time the CPB and the surgery is over.
onset timeThe time from TCI etomidate or propofol to the disappearance of eyelash reflex,up to 10 minutes.The time period from TCI etomidate or propofol to the disappearance of eyelash reflex.
Heart ratefrom the beginning of induction to the surgery over, up to 6 hrs.Heart rate is monitored and recorded at 9 time points, including 10 minutes before induction,the right moment after induction of anesthesia and tracheal intubation,the beginning of surgery and the cardiopulmonary bypass(CPB),the time the ascending aorta is blocked and unstuck,the time the CPB and the surgery is over.
DeliriumThe right moment of patients'leaving off PACU, expected to be 2 h from the end the of operationUsing Confusion Assessment Method for the Intensive Care Unit(CAM-ICU) to screening of delirium.
Number of Participants with Serious and Non-Serious Adverse EventsUp to 1 monthNumber of Participants with Serious and Non-Serious Adverse Events including major adverse cardiovascular and cerebrovascular event such as cardiac infraction,stroke, acute renal failure, re-surgery,and death. Safety Issue?: Yes

Other

MeasureTime frameDescription
Dosage of anesthesia drugfrom the beginning of induction of anesthesia to the surgery over, up to 6 hrs.record the dosage of the anesthesia drug including propofol and etomidate, sufentanyl and rocuronium used during the period of maintenance of anesthesia.
Respiratory rates(HR)from the beginning of induction to the surgery over, up to 6 hrs.Respiratory rate is monitored and recorded at 9 time points, including 10 minutes before induction,the right moment after induction of anesthesia and tracheal intubation,the beginning of surgery and the cardiopulmonary bypass(CPB),the time the ascending aorta is blocked and unstuck,the time the CPB and the surgery is over.
pulse blood oxygen saturation (SPO2)from the beginning of induction to the surgery over, up to 6 hrs.pulse blood oxygen saturation is monitored and recorded at 9 time points, including 10 minutes before induction,the right moment after induction of anesthesia and tracheal intubation,the beginning of surgery and the cardiopulmonary bypass(CPB),the time the ascending aorta is blocked and unstuck,the time the CPB and the surgery is over.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026